Also known as آسٹیوپوروسس مینجمنٹ
Internal Medicine Specialist
M.B.B.S., F.C.P.S.
Internal Medicine Specialist
M.B.B.S. , F.C.P.S. (Internal Medicine Specialist)
Endocrinologist
MBBS, Diploma in Diabetology, MSc (Diabetes & Endocrinology)
Endocrinologist
MBBS, Diploma in Diabetology, MSc (Diabetes & Endocrinology)
Rheumatologist
M.B.B.S., F.C.P.S. (General Medicine), F.C.P.S. (Rheumatology)
Internal Medicine Specialist
M.B.B.S, M.D (Internal Medicine)
Internal Medicine Specialist
M.B.B.S., F.C.P.S.
Endocrinologist
MBBS, MRCP (Diabetes & Endocrinology), CCT (Endocrinology & Diabetes), CCT General Internal Medicine, FRCP
Endocrinologist
MBBS, MRCP (Diabetes & Endocrinology), CCT (Endocrinology & Diabetes), CCT General Internal Medicine, FRCP
Cardiologist
M.B.B.S., M.Phil (Clinical Pharmacology), Dip. Diabetes, Ph.D Scholar (Clinical Pharmacology), M.D (Cardiology)
Cardiologist
M.B.B.S., M.Phil (Clinical Pharmacology), Dip. Diabetes, Ph.D Scholar (Clinical Pharmacology), M.D (Cardiology)
Rheumatologist
MBBS, FCPS (Medicine), Specialty Certificate (Rheumatology)
Rheumatologist
MBBS, FCPS (Medicine), Specialty Certificate (Rheumatology)
Internal Medicine Specialist
MBBS, FCPS (Medicine)
Bisphosphonates are used as first-line pharmacologictreatment for osteoporosis. In patients who cannot tolerate or whose symptoms do not improve with bisphosphonate therapy, teriparatide (Forteo) and denosumab (Prolia) are effective alternative medications to prevent osteoporotic fractures